Key result
Next-generation sequencing detected fusion genes in 16 of 63 (25.4%) archival formalin-fixed paraffin-embedded sarcoma tissue samples.
Why the study?
Does next-generation sequencing (NGS) analysis detect fusion transcripts in archival FFPE sarcoma tissues?
Observational (n=63)
Does next-generation sequencing (NGS) analysis detect fusion transcripts in archival FFPE sarcoma tissues?
NGS analysis can successfully detect fusion genes in archival FFPE sarcoma tissues, offering a powerful alternative to traditional methods despite challenges with RNA fragmentation.
Supports NGS feasibility on archival FFPE sarcoma samples; leaves open clinical utility pending prospective validation.
Most sarcomas are highly aggressive, and cause necrosis and hemorrhage. The diagnosis of sarcoma is challenging because of the lack of specificity of immunohistochemical staining; however, molecular biological approaches, such as genetic mutation, chromosomal translocation, and gene amplification, are promising. In this study, we extracted RNA from formalin-fixed paraffin-embedded (FFPE) tissue derived from surgically resected specimens of sarcoma stored for various periods and performed next-generation sequencing (NGS) analysis by MiniSeq using the Archer Fusion-Plex Sarcoma Panel. RNA was extracted from 63 FFPE tissue samples, and the degree of RNA degradation was assessed. The number of reads and fragment lengths were evaluated by NGS analysis. RNA extraction and cDNA synthesis were successful in 56 cases and library preparation was possible. Fusion genes were detected in 16 of 63 archived FFPE tissue samples in this study. However, in 18 cases, fragmentation was strong, and high-quality libraries could not be obtained. Nevertheless, comprehensive analysis of fusion genes with high sequence specificity by NGS can be a powerful alternative to reverse transcription-polymerase chain reaction and fluorescence in situ hybridization methods.
No takes yet. Share an insight, caveat, or question.
Fujii et al. (2022) conducted an observational in Sarcoma (n=63). Next-generation sequencing (NGS) analysis was evaluated on Detection of fusion genes. Next-generation sequencing detected fusion genes in 16 of 63 (25.4%) archival formalin-fixed paraffin-embedded sarcoma tissue samples.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: